EC-5026 | Interleukin Related interleukin-related.com

Product Name :
EC-5026

Search keywords :
EC5026

drugId :
null

Target Vo:
Epoxide hydratase

Target Vo Short Name :
EPHX2

Moa_Name:
Epoxide hydratase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
The University Of California Davis

Active Company_Name :
Eicosis Human Health Inc

Active Indication_Name:
Neuralgia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-FOXO3A (Ser253) Rabbit mAb In Vivo
PUMA Rabbit mAb custom synthesis
53BP1 Antibody: 53BP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 214 kDa, targeting to TP53BP1. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts